Cystic Fibrosis Foundation Sells Vertex Royalty Rights for $3.3 Billion
News
The Cystic Fibrosis Foundation recently announced its not-for-profit branch, Cystic Fibrosis Foundation Therapeutics, has signed a strategic transfer of owned Vertex Pharmaceuticals royalty rights to Royalty Pharma for $3.3 billion. ... Read more